FG
BMY icon

Fairman Group’s Bristol-Myers Squibb BMY Stock Holding History

Fairman Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.5K Hold
718
– – 0.04% 102
2025
Q4 		$38.7K Hold
718
– – 0.03% 111
2025
Q3 		$32.4K Hold
718
– – 0.03% 120
2025
Q2 		$33.2K Sell
718
-101
-12% -$4.96K 0.03% 115
2025
Q1 		$46.3K Hold
819
– – 0.04% 99
2024
Q4 		$46.3K Hold
819
– – 0.04% 109
2024
Q3 		$42.4K Hold
819
– – 0.04% 117
2024
Q2 		$34K Hold
819
– – 0.03% 127
2024
Q1 		$44.4K Hold
819
– – 0.04% 105
2023
Q4 		$42K Buy
+819
New +$43K 0.04% 114

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fairman Group's BMY Position: Q1 2026 in Review

Fairman Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 718 shares worth $43.5K. The position accounts for 0.04% of the portfolio, ranked #102.

Fairman Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $46.3K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fairman Group held 718 shares of Bristol-Myers Squibb worth $43.5K as of Q1 2026.
  • Fairman Group left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.04% of Fairman Group's portfolio in Q1 2026, its #102 holding.
  • Fairman Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Fairman Group's Bristol-Myers Squibb position peaked at $46.3K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fairman Group's 13F filing for Q1 2026, filed 23 Apr 2026.